What Does Elpen Pharmaceutical Co. Inc. Do?

Total employees760
HeadquartersPikermi
Founded1965

ELPEN Pharmaceutical Co. Inc. is a leading Greek pharmaceutical company, established in 1965. It is actively involved in the research, development, manufacturing, marketing, and export of a wide range of pharmaceutical products. ELPEN is committed to improving patient quality of life and advancing healthcare through innovation, particularly in therapeutic areas such as cardiology, respiratory diseases, central nervous system (CNS) disorders, and oncology. The company emphasizes high-quality manufacturing standards and has a significant international presence, exporting to numerous countries worldwide.

Where Is Elpen Pharmaceutical Co. Inc.'s Headquarters?

HQ Function

Serves as the central hub for research and development (R&D), manufacturing of pharmaceutical products, quality control, corporate administration, strategic planning, and international operations management.

Notable Features:

The campus includes state-of-the-art research laboratories, modern manufacturing plants compliant with EU Good Manufacturing Practices (GMP), an advanced logistics center, and administrative offices. It also houses ELPEN's Experimental Research Center.

Work Culture:

ELPEN fosters a work culture centered on scientific excellence, innovation, collaboration, and a strong ethical commitment to patient well-being and product quality. There is an emphasis on continuous learning, professional development, and teamwork.

HQ Significance:

The Pikermi headquarters is crucial to ELPEN's identity and operations, representing a major hub for pharmaceutical innovation and production in Greece. It supports the company's domestic leadership and its growing export activities, contributing significantly to the Greek economy and healthcare sector.

Values Reflected in HQ: The headquarters reflects ELPEN's core values: People (through its focus on employee well-being and development), Quality (via GMP-certified manufacturing and R&D standards), Responsibility (commitment to healthcare and ethical practices), Innovation (evident in its research facilities), and Extroversion (supporting its global outreach).

Location:

ELPEN Pharmaceutical Co. Inc. has a significant global presence, exporting its pharmaceutical products to over 40 countries across Europe, Asia, the Middle East, and Africa. This international reach is supported by a network of subsidiaries (like ELPEN Pharma GmbH in Germany), strategic partnerships, and distribution agreements. Globally, ELPEN supports functions including international sales and marketing, business development, regulatory affairs tailored to diverse market requirements, and participation in international research collaborations and clinical trials.

Street Address:

95 Marathonos Ave.

City:

Pikermi

State/Province:

Attica

Country:

Greece

Where Else Does Elpen Pharmaceutical Co. Inc. Operate Around the World?

Munich, Germany

Address: ELPEN Pharma GmbH, Stahlgruberring 42, 81829 München, Germany

To strengthen ELPEN's foothold in the significant German pharmaceutical market, manage local commercial operations, build relationships with healthcare professionals and distributors, and navigate regional regulatory landscapes.

Spata, Attica, Greece

Address: Specific address for new R&D park in Spata under development (near Athens International Airport).

To become a cornerstone for future innovation, development of new therapies, and increased manufacturing output for both domestic and international markets, further solidifying ELPEN's role as a leader in pharmaceutical R&D in Greece.

Buying Intent Signals for Elpen Pharmaceutical Co. Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Elpen Pharmaceutical Co. Inc.? Meet the Executive Team

As of April 2025, Elpen Pharmaceutical Co. Inc.' leadership includes:

Dimitrios Pentafragas - Chairman of the Board & CEO
Konstantinos Pentafragas - Vice Chairman of the Board & Deputy CEO
Theodoros Tryfon - Vice Chairman of the Board
Vasileios Pentafragas - General Manager
Eleni Pentafraga - Director of Human Resources & Member of the BoD
George Pentafragas - Research & Development Director

Who's Investing in Elpen Pharmaceutical Co. Inc.?

Elpen Pharmaceutical Co. Inc. has been backed by several prominent investors over the years, including:

Privately Held/Family-Owned

What Leadership Changes Has Elpen Pharmaceutical Co. Inc. Seen Recently?

Hire0
Exits0

As a privately held company, ELPEN Pharmaceutical Co. Inc. does not frequently publicize internal executive changes. No major executive hires or exits have been prominently reported in publicly available news sources over the last 12 months. Leadership changes are typically managed internally, with continuity often seen in family-owned businesses.

What Technology (Tech Stack) Is Used byElpen Pharmaceutical Co. Inc.?

Discover the tools Elpen Pharmaceutical Co. Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Elpen Pharmaceutical Co. Inc. Email Formats and Examples

ELPEN Pharmaceutical Co. Inc. likely utilizes standard corporate email formats. Based on common practices for companies with the domain 'elpen.gr', the most probable formats involve combinations of the employee's first and last names.

[first_initial][last]@elpen.gr (e.g., jdoe@elpen.gr) or [first].[last]@elpen.gr (e.g., jane.doe@elpen.gr)

Format

info@elpen.gr (general contact)

Example

70%

Success rate

What's the Latest News About Elpen Pharmaceutical Co. Inc.?

European Pharmaceutical ReviewFebruary 20, 2024

ELPEN invests €150m in new R&D centre and manufacturing plants

ELPEN Pharmaceutical is investing €150 million in a new research and development center in Spata, Attica, and two new manufacturing plants. This investment aims to boost its R&D capabilities, increase production capacity for existing and new drugs, and create over 800 new jobs....more

elpen.grMay 16, 2023

ELPEN Pharmaceutical Co. Inc. receives Great Place to Work® certification for 2023-2024

ELPEN has been officially certified as a Great Place to Work® in Greece for the period 2023-2024. This recognition highlights the company's commitment to fostering a positive, supportive, and fair work environment for its employees....more

Ekathimerini.com / ELPEN Press ReleaseOctober 5, 2023

ELPEN Group CEO presents new investment plan at Delphi Economic Forum USA

ELPEN's Co-CEO, Konstantinos Pentafragas, presented the company's extensive investment program, including the new R&D park and manufacturing facilities, at the Delphi Economic Forum in Washington D.C., highlighting its contribution to Greece's economic growth and pharmaceutical innovation....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Elpen Pharmaceutical Co. Inc., are just a search away.